Coxiella burnetii infection (Q fever) mimicking systemic lupus erythematosus: two cases.

Abstract:

:Q fever has extremely polymorphic features, and has been reported to be associated with positivity of several autoimmune antibodies. We report two cases of atypical Q fever with a clinical presentation highly suggestive of an inflammatory systemic disease with positivity of autoimmune antibodies, mimicking systemic lupus erythematosus.

journal_name

Lupus

journal_title

Lupus

authors

Durupt S,Puget M,Lega JC,Durieu I,Reynaud Q

doi

10.1177/0961203317747721

subject

Has Abstract

pub_date

2017-01-01 00:00:00

pages

961203317747721

eissn

0961-2033

issn

1477-0962

pub_type

杂志文章

相关文献

LUPUS文献大全
  • Monoclonal gammopathy in systemic lupus erythematosus.

    abstract::In order to ascertain the incidence of monoclonal gammopathy (MG) in systemic lupus erythematosus (SLE), 120 SLE patients were evaluated. Four patients (3.3%), two of whom were under 50 years of age, were found to have a monoclonal immunoglobulin in their serum. Our data agree with the previous literature in demonstra...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339200100410

    authors: Porcel JM,Ordi J,Tolosa C,Selva A,Castro-Salomo A,Vilardell M

    更新日期:1992-08-01 00:00:00

  • T cell vaccination in systemic lupus erythematosus with autologous activated T cells.

    abstract::Systemic lupus erythematosus (SLE) is an autoreactive T cell mediated autoimmune disease. Immunization with inactivated autoreactive T cells may induce idiotype anti-idiotypic reaction to deplete specific subsets of autoreactive T cells involved in SLE. Six SLE patients unsuitable or refused to use immunosuppressants ...

    journal_title:Lupus

    pub_type: 临床试验,杂志文章

    doi:10.1191/0961203305lu2239oa

    authors: Li ZG,Mu R,Dai ZP,Gao XM

    更新日期:2005-01-01 00:00:00

  • Effectiveness of pharmaceutical care for drug treatment adherence in women with lupus nephritis in Rio de Janeiro, Brazil: a randomized controlled trial.

    abstract:OBJECTIVE:Studies have been conducted to determine the causal factors and clinical consequences of non-adherence to treatment in systemic lupus erythematosus (SLE). However, no interventions have been performed to increase drug adherence. Our objective was to assess the effectiveness of pharmaceutical care (PC) for dru...

    journal_title:Lupus

    pub_type: 杂志文章,随机对照试验

    doi:10.1177/0961203319877237

    authors: Oliveira-Santos M,Verani JFS,Camacho LAB,de Andrade CAF,Klumb EM

    更新日期:2019-10-01 00:00:00

  • Anti-insulin antibodies and the natural autoimmune response in systemic lupus erythematosus.

    abstract::Systemic lupus erythematosus (SLE) is characterized by the finding of ample serum autoantibodies. The role and the origin of many of these antibodies are still obscure. The aim of this work was to study the occurrence of anti-insulin antibodies (AIA) in SLE, and to postulate, based on AIA determination, on the mechani...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120301669081314

    authors: Lidar M,Braf A,Givol N,Langevitz P,Pauzner R,Many A,Livneh A

    更新日期:2001-01-01 00:00:00

  • Human Fc gamma receptor IIA (FcgammaRIIA) genotyping and association with systemic lupus erythematosus (SLE) in Chinese and Malays in Malaysia.

    abstract::SLE is an autoimmune and polygenic disorder characterized by an accumulation and deposition of immune complexes. Several studies have indicated differential impact of FcgammaR polymorphism genotypes in different ethnic groups studied. The Fc receptor for IgG class IIA gene (FcgammaRIIA) occurs in two allelic forms. Th...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120399678847876

    authors: Yap SN,Phipps ME,Manivasagar M,Tan SY,Bosco JJ

    更新日期:1999-01-01 00:00:00

  • A case of progressive multifocal leukoencephalopathy in a lupus patient treated with belimumab.

    abstract::Belimumab is a monoclonal antibody against soluble B-lymphocyte stimulator, an essential growth factor for B-cell maturation and activation, which was approved by the US FDA in 2011 for patients with active autoantibody-positive systemic lupus erythematosus (SLE) who have failed standard treatment. Here we present the...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314524292

    authors: Fredericks CA,Kvam KA,Bear J,Crabtree GS,Josephson SA

    更新日期:2014-06-01 00:00:00

  • Acinetobacter pericarditis with tamponade in a patient with systemic lupus erythematosus.

    abstract::We describe a case of active systemic lupus erythematosus (SLE) complicated with a large amount of pericardial effusion with diastolic collapse of right ventricle suggestive of tamponade. Isolates from surgical drainage of pericardial fluid showed Acinetobacter baumannii exhibiting multiple antibiotics resistance. Des...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/096120339700600513

    authors: Lam SM,Huang TY

    更新日期:1997-01-01 00:00:00

  • Association between HLA class II antigens and primary antiphospholipid syndrome from the south of Spain.

    abstract::Recent studies have suggested an association between primary antiphospholipid syndrome (PAPS), antiphospholipid antibodies and some major histocompatibility complex (MHC) antigens. We have studied the relationship between MHC class II antigens and PAPS in 19 patients from the south of Spain. Univariant analysis showed...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339500400111

    authors: Camps MT,Cuadrado MJ,Ocón P,Alonso A,Gutierrez A,Guil M,Grana MI,de Ramón E

    更新日期:1995-02-01 00:00:00

  • Vaccination and systemic lupus erythematosus: the bidirectional dilemmas.

    abstract::Vaccination has been perhaps the most important achievement in medicine of the last century. A hoard of infectious diseases that used to claim the lives of many, especially children, have been prevented and some even eradicated. However, it is possible that within this gift there is hidden a 'Trojan Horse'. During the...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/096120301673085478

    authors: Aron-Maor A,Shoenfeld Y

    更新日期:2001-01-01 00:00:00

  • Juvenile systemic lupus erythematosus in multicase families from Saudi Arabia: comparison of clinical and laboratory variables with sporadic cases.

    abstract::The object of this study was to compare patients with familial versus sporadic systemic lupus erythematosus (SLE) with respect to clinical, laboratory variables and outcome. The familial SLE group comprised 12 patients while the comparative group comprised 24 patients selected by systemic sampling from our pediatric r...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120330607192

    authors: Al-Mayouf SM,Al Sonbul A

    更新日期:2006-01-01 00:00:00

  • An in vitro model to mimic the thrombotic occlusion of small vessels in catastrophic antiphospholipid syndrome (CAPS).

    abstract::Platelet activation and decrease in platelet count characterize the development of the most feared form of antiphospholipid syndrome (APS), i.e. catastrophic APS (CAPS). We aimed to assess if immuno-affinity purified anti-β2-glycoprotein I (aβ2GPI) antibodies enhance platelet activation inducing a significant flow obs...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319886915

    authors: Pontara E,Cheng C,Cattini MG,Bison E,Pelloso M,Denas G,Pengo V

    更新日期:2019-12-01 00:00:00

  • Human monoclonal antibodies against the complex of phosphatidylserine and prothrombin from patients with the antiphospholipid antibodies.

    abstract::The presence of antibodies against the complex of prothrombin and phosphatidylserine (aPS/PT) more significantly correlates with manifestations of antiphospholipid syndrome (APS) and with the presence of lupus anticoagulants (LA) than antibodies against prothrombin bound to oxygenated polystyrene (aPT-A). To investiga...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203307078680

    authors: Horita T,Ichikawa K,Kataoka H,Yasuda S,Atsumi T,Koike T

    更新日期:2007-01-01 00:00:00

  • Intrarenal macrophage infiltration induced by T cells is associated with podocyte injury in lupus nephritis patients.

    abstract::Proteinuria is the hallmark of clinical manifestation of disease activity in lupus nephritis (LN) patients, which arises from direct or indirect podocyte injury. This study is to explore the relationship between intrarenal T cell infiltration and podocyte injury in lupus nephritis (LN), and to understand the potential...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316646861

    authors: Ma R,Jiang W,Li Z,Sun Y,Wei Z

    更新日期:2016-12-01 00:00:00

  • Disease activity, cumulative damage and quality of life in systematic lupus erythematosus: results of a cross-sectional study.

    abstract::The relationship between disease activity, cumulative damage and self-reported quality of life was examined in 96 patients with Systematic Lupus Erythematosus (SLE). Disease activity was measured by the SLE Disease Activity Index (SLEDAI) and cumulative damage by the Systematic Lupus International Cooperating Clinics/...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339700600305

    authors: Hanly JG

    更新日期:1997-01-01 00:00:00

  • Cardio-pulmonary involvement in juvenile systemic lupus erythematosus.

    abstract::Cardio-pulmonary manifestations of systemic lupus erythematosus (SLE) are well recognized in adults. We report the occurrence of clinically significant cardio-pulmonary disease in a cohort of predominantly Caucasian children with SLE. All children with SLE attending the Royal Liverpool Children's NHS Trust between 199...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203305lu2073oa

    authors: Beresford MW,Cleary AG,Sills JA,Couriel J,Davidson JE

    更新日期:2005-01-01 00:00:00

  • The dual role of innate immunity in antiphospholipid syndrome and systemic lupus erythematosus.

    abstract::Antiphospholipid syndrome (APS), as a primary disease or a secondary syndrome in systemic lupus erythematosus (SLE), is characterized by the presence of antiphospholipid antibodies (aPL) and a clinical event. It is likely that both genetic and environmental factors lead to the development of aPL and progression to dis...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314548248

    authors: Salem D,Subang R,Laplante P,Levine JS,Rauch J

    更新日期:2014-10-01 00:00:00

  • Infodemiology of systemic lupus erythematous using Google Trends.

    abstract::Objective People affected by chronic rheumatic conditions, such as systemic lupus erythematosus (SLE), frequently rely on the Internet and search engines to look for terms related to their disease and its possible causes, symptoms and treatments. 'Infodemiology' and 'infoveillance' are two recent terms created to desc...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203317691372

    authors: Radin M,Sciascia S

    更新日期:2017-07-01 00:00:00

  • Mechanisms involved in the p62-73 idiopeptide-modulated delay of lupus nephritis in SNF(1) mice.

    abstract::The F(1) progeny of the (SWR × NZB) cross develop a lupus-like disease with high serum titers of autoantibodies, and increased frequency and severity of immune complex-mediated glomerulonephritis in females. In previous work, we found that an idiotypic peptide corresponding to aa62-73 (p62-73) of the heavy chain varia...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203312461964

    authors: Nyland JF,Stoll ML,Jiang F,Feng F,Gavalchin J

    更新日期:2012-12-01 00:00:00

  • Lymphocyte subsets in a large cohort of patients with systemic lupus erythematosus.

    abstract::In search of markers of disease activity in patients with SLE we have investigated blood lymphocyte subsets from a large cohort of patient. Seventy-one patients were studied using a well-defined panel of fluorescent monoclonal antibodies which recognize the major T, B and NK lymphocyte subsets and activated cells. Flo...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339300200404

    authors: Erkeller-Yüsel F,Hulstaart F,Hannet I,Isenberg D,Lydyard P

    更新日期:1993-08-01 00:00:00

  • Autoimmune response following influenza vaccination in patients with autoimmune inflammatory rheumatic disease.

    abstract::Vaccines have undoubtedly brought overwhelming benefits to mankind and are considered safe and effective. Nevertheless, they can occasionally stimulate autoantibody production or even a recently defined syndrome known as autoimmune/inflammatory syndrome induced by adjuvants (ASIA). There is scarce data regarding autoi...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203311429817

    authors: Perdan-Pirkmajer K,Thallinger GG,Snoj N,Čučnik S,Žigon P,Kveder T,Logar D,Praprotnik S,Tomšič M,Sodin-Semrl S,Ambrožič A

    更新日期:2012-02-01 00:00:00

  • Prolactin levels in patients with systemic lupus erythematosus: a case controlled study.

    abstract::Recent accumulated evidence suggests that prolactin (PRL) is an important immunomodulator and might have a role in the pathogenesis of systemic lupus erythematosus (SLE). Our aim was to assess the frequency of hyperprolactinemia in women with SLE and to evaluate its correlation with disease activity. PRL plasma levels...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120398678920361

    authors: Jimena P,Aguirre MA,López-Curbelo A,de Andrés M,Garcia-Courtay C,Cuadrado MJ

    更新日期:1998-01-01 00:00:00

  • Relationship of anticardiolipin antibodies and antiphospholipid syndrome to HLA-DR7 in Mexican patients with systemic lupus erythematosus (SLE).

    abstract::We studied IgG and IgM anticardiolipin antibodies (aCL) by an ELISA method in 80 Mexican systemic lupus erythematosus (SLE) patients and 378 of their first degree relatives. Sixty five percent of SLE patients and 16% of their relatives were positive for aCL. We also determined allele and haplotype frequencies of Major...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339700600108

    authors: Granados J,Vargas-Alarcón G,Drenkard C,Andrade F,Melín-Aldana H,Alcocer-Varela J,Alarcón-Segovia D

    更新日期:1997-01-01 00:00:00

  • Is the development of drug-related lupus a contraindication for switching from one TNF alpha inhibitor to another?

    abstract::The use of TNF alpha (TNFalpha) inhibitors has made a strong impact on the management of rheumatoid and psoriatic arthritis, ankylosing spondylitis and Crohn disease. Side effects of these agents include the development of autoantibodies and a lupus-like syndrome (drug-related lupus, DRL). Here, a case of a patient wh...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308093922

    authors: Kocharla L,Mongey AB

    更新日期:2009-02-01 00:00:00

  • Pregnancies in women with systemic lupus erythematosus and antiphospholipid antibodies.

    abstract::Systemic lupus erythematosus (SLE) has preponderance in women in their childbearing years; consequently pregnancy has always been an important issue of concern for the patient and the treating physician. Based upon numerous reports on successful pregnancy outcomes in the past decades, the initial advice against pregna...

    journal_title:Lupus

    pub_type: 评论,杂志文章

    doi:10.1177/0961203315627201

    authors: Schreiber K

    更新日期:2016-04-01 00:00:00

  • Infections in outpatients with systemic lupus erythematosus: a prospective study.

    abstract::The objective of this study was to assess the incidence and risk factors of infections in 200 SLE outpatients. All outpatients with active or inactive SLE without infections in the previous month were included. They were assessed every 3 months. Major infections were those requiring hospitalization and parental antibi...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120301678416088

    authors: Zonana-Nacach A,Camargo-Coronel A,Yañez P,Sánchez L,Jimenez-Balderas FJ,Fraga A

    更新日期:2001-01-01 00:00:00

  • Long-term systemic lupus erythematosus disease control after allogeneic bone marrow transplantation.

    abstract::Systemic lupus erythematosus (SLE), a disorder of the immune system, is potentially curable by allogeneic bone marrow transplantation (alloBMT). Until recently, alloBMT was limited by donor availability and toxicity. Reduced intensity conditioning (RIC) combined with post-transplantation cyclophosphamide (PTCy) has im...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316669242

    authors: Gladstone DE,Petri M,Bolaños-Meade J,Dezern AE,Jones RJ,Fine D,Brodsky RA

    更新日期:2017-06-01 00:00:00

  • Early-stage predictors for treatment responses in patients with active lupus nephritis.

    abstract:OBJECTIVE:We analyzed data of lupus nephritis (LN) patients to find parameters that can predict remission. METHODS:Sixty-four LN patients who were diagnosed with class III, IV, V or V + III/IV by renal biopsy and were followed up for more than six months in our center were enrolled retrospectively. Receiver operating ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319826703

    authors: Liu G,Wang H,Le J,Lan L,Xu Y,Yang Y,Chen J,Han F

    更新日期:2019-03-01 00:00:00

  • Speckle tracking echocardiography for the evaluation of left ventricular function in children with systemic lupus erythematosus.

    abstract:BACKGROUND:Many studies in adult patients with systemic lupus erythematosus (SLE) have demonstrated that myocardial dysfunction was significantly associated with enhanced disease activity. However, similar studies in paediatric patients with SLE are limited. The aim of this study was to evaluate the role of speckle tra...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320942296

    authors: Emara M,Hafez MA,El-Bendary A,Razaky OE

    更新日期:2020-10-01 00:00:00

  • Preventing the development of SLE: identifying risk factors and proposing pathways for clinical care.

    abstract::Although challenging, developing evidence-based approaches to an early and accurate diagnosis of systemic lupus erythematosus is a key approach to preventing disease and lupus-associated morbidity and mortality. Advances in our understanding of preclinical and incomplete lupus erythematosus have enabled the identifica...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203316640367

    authors: Choi MY,Barber MR,Barber CE,Clarke AE,Fritzler MJ

    更新日期:2016-07-01 00:00:00

  • A clinical and serological comparison of familial and non-familial systemic lupus erythematosus in Ireland.

    abstract::Seventeen families, in which the diagnosis of SLE could be verified in two relatives, were included in the study. The diagnosis was made according to the revised 1982 ARA criteria. We compared the 34 cases of familial SLE in these 17 families with 34 non-familial SLE controls matched for age, sex, ethnicity and durati...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339600500408

    authors: Gourley IS,Cunnane G,Bresnihan B,FitzGerald O,Bell AL

    更新日期:1996-08-01 00:00:00